Axsome Therapeutics, Inc. (AXSM)
142.20
-1.86
(-1.29%)
USD |
NASDAQ |
Oct 27, 16:00
142.22
+0.02
(+0.02%)
After-Hours: 20:00
Axsome Therapeutics Market Cap : 7.437B for Oct. 27, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 27, 2026 | 7.437B |
| October 26, 2026 | 7.534B |
| October 23, 2026 | 7.586B |
| October 22, 2026 | 8.162B |
| October 21, 2026 | 8.175B |
| October 20, 2026 | 8.346B |
| October 19, 2026 | 8.149B |
| October 16, 2026 | 8.218B |
| October 15, 2026 | 8.462B |
| October 14, 2026 | 8.484B |
| October 13, 2026 | 8.176B |
| October 12, 2026 | 8.682B |
| October 09, 2026 | 8.805B |
| October 08, 2026 | 8.895B |
| October 07, 2026 | 9.046B |
| October 06, 2026 | 9.118B |
| October 05, 2026 | 9.261B |
| October 02, 2026 | 9.375B |
| October 01, 2026 | 9.522B |
| September 30, 2026 | 9.644B |
| September 29, 2026 | 9.735B |
| September 28, 2026 | 10.14B |
| September 25, 2026 | 10.20B |
| September 24, 2026 | 10.25B |
| September 23, 2026 | 10.12B |
| Date | Value |
|---|---|
| September 22, 2026 | 10.62B |
| September 21, 2026 | 10.75B |
| September 18, 2026 | 10.87B |
| September 17, 2026 | 11.21B |
| September 16, 2026 | 11.09B |
| September 15, 2026 | 10.67B |
| September 14, 2026 | 11.33B |
| September 11, 2026 | 11.55B |
| September 10, 2026 | 11.04B |
| September 09, 2026 | 11.02B |
| September 08, 2026 | 10.87B |
| September 04, 2026 | 10.81B |
| September 03, 2026 | 10.90B |
| September 02, 2026 | 10.98B |
| September 01, 2026 | 10.61B |
| August 31, 2026 | 10.38B |
| August 28, 2026 | 10.41B |
| August 27, 2026 | 10.79B |
| August 26, 2026 | 10.83B |
| August 25, 2026 | 10.75B |
| August 24, 2026 | 10.74B |
| August 21, 2026 | 10.87B |
| August 20, 2026 | 10.88B |
| August 19, 2026 | 11.41B |
| August 18, 2026 | 11.28B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.207T |
| Filana Therapeutics, Inc. | 31.32M |
| CorMedix, Inc. | 621.34M |
| Eloxx Pharmaceuticals, Inc. | 53.85M |
| Breakthrough Chemistry, Inc. | 0.8756M |
Market Cap Related Metrics
| PS Ratio | 9.323 |
| Price to Book Value | 89.28 |
| Price | 142.20 |
| Earnings Yield | -2.64% |